BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2007
View Archived Issues
Primate studies elucidate activity of novel small-molecule, cholesterol-lowering agents
Read More
Vasohibin beneficial in early diabetic nephropathy model
Read More
A TGF-beta inhibitor protects against radiation-induced lung damage
Read More
Insmed positioned to initiate clinical studies of follow-on biologics products
Read More
Cardium initiates phase IIb MATRIX clinical study of Excellarate for diabetic ulcers
Read More
Pharmacological interventions for hepatic pathologies discussed at Liver Meeting
Read More
Merck Serono extends rights to Rigel's R-763/AS-703569 to include Japan
Read More
Advanced Life Sciences reports positive results from Trial CL-05 of cethromycin
Read More
BioLineRx enters worldwide license agreement with Yissum and Hadasit for BL-4060
Read More
Nymox completes 2-year follow-up study of NX-1207 for benign prostatic hyperplasia
Read More
Novartis initiates phase II study of QVA-149 for chronic obstructive pulmonary disease
Read More
Panacea makes CC Detect available as diagnostic test for colon cancer
Read More
Introgen reports summary data from clinical studies of p53 tumor suppressor Advexin
Read More
HealthLinx successfully completes phase II biomarker trial on the OvPlex panel
Read More
Innovive initiates STAR-1 phase II clinical trial of tamibarotene
Read More
Cogentus initiates phase III clinical trials of CGT-2168 in antiplatelet therapy
Read More
Novel antiobesity agents described in recent patent literature
Read More
Genta reports positive data from phase I clinical trial of G-4544 for accelerated bone loss
Read More
Taisho reports on novel antagonists of the MCH receptor 1
Read More
FDA authorizes IND for Athersys' MultiStem for bone marrow transplant support
Read More
LipoNova confirms U.S. and E.U. registration strategy for renal cell cancer vaccine Reniale
Read More
Adventrx meets primary endpoint in bioequivalence clinical study of ANX-530
Read More
FDA accepts Discovery Laboratories' response to approvable letter for Surfaxin
Read More
Thallion reports positive safety and efficacy data from phase I/II trial of ECO-4601
Read More
Gilead submits NDA to FDA for aztreonam lysine for inhalation for cystic fibrosis
Read More
CHMP adopts negative opinion on marketing authorization for Tysabri for Crohn's disease
Read More
FDA approves supplemental NDA for Nexavar for unresectable hepatocellular carcinoma
Read More
CHMP recommends extended indication for Angiox for acute coronary syndromes
Read More